Bio-polymeric transferrin-targeted temozolomide nanoparticles in gel for synergistic post-surgical GBM therapy
- 24 August 2022
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 14 (35) , 12773-12788
Abstract
Spatiotemporal targeting of anti-glioma drugs remains a pressing issue in glioblastoma (GBM) treatment. We challenge this issue by developing a minimally invasive in situ implantable hydrogel implant comprising transferrin-targeted temozolomide–miltefosine nanovesicles in the surgically resected GBM cavity (tumour bed). Injection of the “nanovesicle in hydrogel system” in orthotopic GBM-bearing mice improved drug penetration into the peri-cavitary region (∼4.5 mm in depth) with the potential to act as a bridge therapy in the immediate postoperative period, before the initiation of adjuvant radiotherapy. The controlled and sustained release of temozolomide over a month in the surgical cavity eradicated the microscopic GBM cells present within the tumour bed, thereby augmenting the efficacy of adjuvant therapy. The drug (temozolomide and miltefosine) combination was tolerable and efficiently inhibited tumour growth, causing significant prolongation of the survival of tumour-bearing mice compared to that with the free drug. Direct implantation at the target site in the brain resulted in spatiotemporal anti-glioma activity with minimal extracranial and systemic distribution. Nanovesicle in flexible hydrogel systems can be used as potential platforms for the post-surgical management of GBM before initiating adjuvant radiation therapy.Keywords
Funding Information
- Lady Tata Memorial Trust
This publication has 27 references indexed in Scilit:
- Transferrin receptors and glioblastoma multiforme: Current findings and potential for treatmentJournal of Clinical Neuroscience, 2015
- Pharmacodynamic and Therapeutic Investigation of Focused Ultrasound-Induced Blood-Brain Barrier Opening for Enhanced Temozolomide Delivery in Glioma TreatmentPLOS ONE, 2014
- Emerging treatment strategies for glioblastoma multiformeEMBO Molecular Medicine, 2014
- Enhanced blood–brain barrier transmigration using a novel transferrin embedded fluorescent magneto-liposome nanoformulationNanotechnology, 2014
- Proapoptotic miltefosine nanovesicles show synergism with paclitaxel: Implications for glioblastoma multiforme therapyCancer Letters, 2013
- Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptorProceedings of the National Academy of Sciences of the United States of America, 2013
- DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental gliomaNeuro-Oncology, 2009
- The safety of temozolomide in the treatment of malignanciesExpert Opinion on Drug Safety, 2009
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Transferrin receptor in normal and neoplastic brain tissue: implications for brain-tumor immunotherapyJournal of Neurosurgery, 1990